Pancreatic Cancer Research

ResearcherPeking University People's HospitalNo recent work listed

Xi-sheng Leng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9822-718X; OpenAlex author ID A5043578707. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper

Papers 2

  1. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.bbrc.2018.02.005↗
  2. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.bbrc.2016.09.099↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weihua Zhu · 2 shared papers, 2016–2018 · strength 0.17
  2. Huahu Guo · 1 shared paper, 2016 · strength 0.07
  3. Yazhou Wang · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.